Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

• Status: Completed
• Trial end date: 2006-10-26
• Target enrollment: 0
• Participant gender: All

Summary

A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shionogi
• Treatments: S 3304

Criteria

INCLUSION CRITERIA

• newly diagnosed non-small cell lung cancer of stage IIIA non-resectable or of stage IIIB without pleural effusion

• ECOG performance status 0-1

• adequate organ function

• clinically indicated and able to receive conventional chemoradiation therapy

EXCLUSION CRITERIA

• patients with prior history of cancer, other than basal cell carcinoma after appropriate treatment, or prior systemic chemotherapy treatment

• patients with other serious intercurrent illness including HIV/AIDS, or contraindicated for paclitaxel/carboplatin or thoracic irradiation treatment